标普和纳斯达克内在价值 联系我们

Monogram Orthopaedics, Inc. MGRM NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
46/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.40
-10%

Monogram Orthopaedics, Inc. (MGRM) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Devices 行业. 公司总部位于 Austin, TX, 美国. 现任CEO为 Benjamin Sexson.

MGRM 拥有 IPO日期为 2023-05-18, 27 名全职员工, 在 NASDAQ Capital Marke, 市值为 $243.79M.

关于 Monogram Orthopaedics, Inc.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

📍 3913 Todd Lane, Austin, TX 78744 📞 512 399 2656
公司详情
所属板块医疗保健
细分行业Medical - Devices
国家美国
交易所NASDAQ Capital Marke
货币USD
IPO日期2023-05-18
首席执行官Benjamin Sexson
员工数27
交易信息
当前价格$6.00
市值$243.79M
52周区间1.918-6.425
Beta0.69
ETF
ADR
CUSIP609786108
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言